首页 > 最新文献

Archives of Gynecology and Obstetrics最新文献

英文 中文
Prenatal diagnosis of 15q13.3 deletion and duplication syndrome: what do we tell the prospective parents? 15q13.3缺失和重复综合征的产前诊断:我们应该告诉准父母什么?
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-22 DOI: 10.1007/s00404-025-08150-z
Xiaojin Luo, Hongqing Liu, Xiaohang Chen, Hongyan Niu, Fei Zhou, Shuxian Zeng, Yuhe Fu, Jinxing Liu, Yanyun Guo

Objective

This retrospective study analyzed ultrasound findings, single nucleotide polymorphism microarray (SNP array) results, pregnancy outcomes, and postnatal follow-up data in fetuses with 15q13.3 deletions or duplications.

Methods

Six fetuses were diagnosed with 15q13.3 deletions and nine with 15q13.3 duplications via SNP array at the prenatal diagnosis center of a single tertiary medical center from August 2017 to December 2024. Maternal demographics, ultrasound findings, SNP array results, pregnancy outcomes, and follow-up information were comprehensively reviewed and analyzed.

Results

The deletions sizes in the six deletions ranged from 744 Kb to 1.87 Mb, primarily involving genes such as MTMR15, MTMR10, TRPM1, KLF13, OTUD7A, and CHRNA7. The overlapping region was located between 31.9 Mb and 32.5 Mb. In the nine duplication cases, the fragment sizes ranged from 419 Kb to 2.13 Mb, with overlapping region located between 31.9 Mb and 32.4 Mb. Among the six cases of fetal deletions, three (50.0%, 3/6) exhibited ultrasound abnormalities. The observed ultrasound phenotypes primarily consisted of cardiovascular malformations, lateral ventriculomegaly, intrauterine growth retardation, cleft lip and palate, abnormal finger development, and polyhydramnios. In the nine cases with fetal duplications, four (44.4%, 4/9) showed ultrasound abnormalities, predominantly featuring cardiovascular malformations, corpus callosum hypoplasia, enlarged gallbladder, lateral ventriculomegaly, and increased nuchal translucency. Among the six deletions cases, parental origin testing was conducted for five cases, two were identified as maternally inherited and three were de novo. In the nine duplications cases, eight underwent parental origin testing, with five being inherited (three paternal and two maternal) and two were de novo. Follow-up assessments revealed that the Case 7 showed speech and motor developmental delays. Case 8 experienced seizure at four years of age. At 18 months, Case 13 was diagnosed with bilateral strabismus.

Conclusion

This study conducted a preliminary assessment of the genotype and phenotype of fetuses with 15q13.3 deletions/duplications, expanding the phenotypic spectrum of this syndrome. The study suggests that prenatal 15q13.3 deletions and duplications may be associated with cardiac malformations and lateral ventriculomegaly, but lack phenotype specificity. Moreover, it is essential to closely monitor the neuropsychiatric development postnatally in fetuses with 15q13.3 deletions and duplications that exhibit normal phenotypes during the prenatal period.

目的:回顾性分析15q13.3基因缺失或重复胎儿的超声表现、单核苷酸多态性微阵列(SNP)检测结果、妊娠结局及产后随访资料。方法:2017年8月至2024年12月,在某三级医疗中心产前诊断中心通过SNP阵列诊断出6例15q13.3缺失胎儿和9例15q13.3重复胎儿。对产妇人口统计学、超声检查结果、SNP阵列结果、妊娠结局和随访信息进行全面回顾和分析。结果:6个缺失的缺失大小从744 Kb到1.87 Mb不等,主要涉及MTMR15、MTMR10、TRPM1、KLF13、OTUD7A和CHRNA7等基因。重叠区位于31.9 ~ 32.5 Mb之间。9例重复中,片段大小在419 ~ 2.13 Mb之间,重叠区位于31.9 ~ 32.4 Mb之间。6例胎儿缺失中,3例(50.0%,3/6)出现超声异常。超声表型主要表现为心血管畸形、侧脑室肿大、宫内发育迟缓、唇腭裂、手指发育异常、羊水过多。9例重复胎儿中,超声异常4例(44.4%,4/9),主要表现为心血管畸形、胼胝体发育不全、胆囊增大、侧脑室肿大、颈部透明度增高。在6例缺失病例中,对5例进行了亲本来源检测,其中2例为母系遗传,3例为新生。在9例重复病例中,8例进行了父母起源测试,其中5例是遗传的(3例是父亲的,2例是母亲的),2例是从头开始的。后续评估显示,病例7表现出语言和运动发育迟缓。病例8在4岁时癫痫发作。病例13在18个月时被诊断为双侧斜视。结论:本研究初步评估了15q13.3缺失/重复胎儿的基因型和表型,扩大了该综合征的表型谱。该研究提示,产前15q13.3缺失和重复可能与心脏畸形和侧脑室肥大有关,但缺乏表型特异性。此外,在产前表现出正常表型的15q13.3缺失和重复的胎儿,有必要密切监测其出生后的神经精神发育。
{"title":"Prenatal diagnosis of 15q13.3 deletion and duplication syndrome: what do we tell the prospective parents?","authors":"Xiaojin Luo,&nbsp;Hongqing Liu,&nbsp;Xiaohang Chen,&nbsp;Hongyan Niu,&nbsp;Fei Zhou,&nbsp;Shuxian Zeng,&nbsp;Yuhe Fu,&nbsp;Jinxing Liu,&nbsp;Yanyun Guo","doi":"10.1007/s00404-025-08150-z","DOIUrl":"10.1007/s00404-025-08150-z","url":null,"abstract":"<div><h3>Objective</h3><p>This retrospective study analyzed ultrasound findings, single nucleotide polymorphism microarray (SNP array) results, pregnancy outcomes, and postnatal follow-up data in fetuses with 15q13.3 deletions or duplications.</p><h3>Methods</h3><p>Six fetuses were diagnosed with 15q13.3 deletions and nine with 15q13.3 duplications via SNP array at the prenatal diagnosis center of a single tertiary medical center from August 2017 to December 2024. Maternal demographics, ultrasound findings, SNP array results, pregnancy outcomes, and follow-up information were comprehensively reviewed and analyzed.</p><h3>Results</h3><p>The deletions sizes in the six deletions ranged from 744 Kb to 1.87 Mb, primarily involving genes such as MTMR15, MTMR10, TRPM1, KLF13, OTUD7A, and CHRNA7. The overlapping region was located between 31.9 Mb and 32.5 Mb. In the nine duplication cases, the fragment sizes ranged from 419 Kb to 2.13 Mb, with overlapping region located between 31.9 Mb and 32.4 Mb. Among the six cases of fetal deletions, three (50.0%, 3/6) exhibited ultrasound abnormalities. The observed ultrasound phenotypes primarily consisted of cardiovascular malformations, lateral ventriculomegaly, intrauterine growth retardation, cleft lip and palate, abnormal finger development, and polyhydramnios. In the nine cases with fetal duplications, four (44.4%, 4/9) showed ultrasound abnormalities, predominantly featuring cardiovascular malformations, corpus callosum hypoplasia, enlarged gallbladder, lateral ventriculomegaly, and increased nuchal translucency. Among the six deletions cases, parental origin testing was conducted for five cases, two were identified as maternally inherited and three were de novo. In the nine duplications cases, eight underwent parental origin testing, with five being inherited (three paternal and two maternal) and two were de novo. Follow-up assessments revealed that the Case 7 showed speech and motor developmental delays. Case 8 experienced seizure at four years of age. At 18 months, Case 13 was diagnosed with bilateral strabismus.</p><h3>Conclusion</h3><p>This study conducted a preliminary assessment of the genotype and phenotype of fetuses with 15q13.3 deletions/duplications, expanding the phenotypic spectrum of this syndrome. The study suggests that prenatal 15q13.3 deletions and duplications may be associated with cardiac malformations and lateral ventriculomegaly, but lack phenotype specificity. Moreover, it is essential to closely monitor the neuropsychiatric development postnatally in fetuses with 15q13.3 deletions and duplications that exhibit normal phenotypes during the prenatal period.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"1991 - 2000"},"PeriodicalIF":2.5,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08150-z.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145342992","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaginal natural orifice transluminal endoscopic surgery (vNOTES) in myomectomy: a novel minimally invasive technique review 阴道自然孔腔内窥镜手术(vNOTES)子宫肌瘤切除术:一种新的微创技术综述。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-22 DOI: 10.1007/s00404-025-08206-0
Liufeng Xu, Jiaying Tao, Jigang Jia, Yonghong Lin, Li He

Vaginal natural orifice transluminal endoscopic surgery (vNOTES) offers several distinct advantages, including an optimal cosmetic result, early resumption of flatus and a shorter hospital stay. This minimally invasive approach has been increasingly and widely adopted in diverse gynecologic procedures. In this review article, we provide detailed steps for performing myomectomy via vNOTES. In addition, we delve into several specific challenges that need to be addressed. It is suggested that surgeons consider incorporating this technique into their routine practice for the treatment of uterine myomas, as it has the potential to offer significant benefits to patients.

阴道自然孔腔内窥镜手术(vNOTES)提供了几个明显的优势,包括最佳的美容效果,早期恢复肠胃胀气和更短的住院时间。这种微创方法已越来越多地被广泛应用于各种妇科手术。在这篇综述文章中,我们提供了通过vNOTES进行子宫肌瘤切除术的详细步骤。此外,我们还深入研究了需要解决的几个具体挑战。建议外科医生考虑将这项技术纳入子宫肌瘤治疗的常规实践中,因为它有可能为患者提供显著的益处。
{"title":"Vaginal natural orifice transluminal endoscopic surgery (vNOTES) in myomectomy: a novel minimally invasive technique review","authors":"Liufeng Xu,&nbsp;Jiaying Tao,&nbsp;Jigang Jia,&nbsp;Yonghong Lin,&nbsp;Li He","doi":"10.1007/s00404-025-08206-0","DOIUrl":"10.1007/s00404-025-08206-0","url":null,"abstract":"<div><p>Vaginal natural orifice transluminal endoscopic surgery (vNOTES) offers several distinct advantages, including an optimal cosmetic result, early resumption of flatus and a shorter hospital stay. This minimally invasive approach has been increasingly and widely adopted in diverse gynecologic procedures. In this review article, we provide detailed steps for performing myomectomy via vNOTES. In addition, we delve into several specific challenges that need to be addressed. It is suggested that surgeons consider incorporating this technique into their routine practice for the treatment of uterine myomas, as it has the potential to offer significant benefits to patients.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"1883 - 1890"},"PeriodicalIF":2.5,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08206-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145343029","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Live birth rates with and without preimplantation genetic testing: a single-center retrospective study 有和没有植入前基因检测的活产率:一项单中心回顾性研究。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-22 DOI: 10.1007/s00404-025-08225-x
Yicheng Wang, Xinting Yu, Yacong Wang, Wending Teng, Hong Xian, Fang Wang

Background

Embryo selection and preimplantation genetic testing (PGT) are used in clinical practice with the aim of improving pregnancy outcomes in patients. However, it remains uncertain whether different PGT techniques improve the live birth rate in patients compared to conventional in vitro fertilization (IVF).

Methods

In this single-center retrospective cohort study, we included couples undergoing their first IVF-assisted conception cycle with only their first single frozen embryo transfer. All couples were fertilized by intracytoplasmic sperm injection (ICSI) and had three or more high-quality blastocysts on the fifth day of embryo culture. The PGT group screened the optimal blastocysts for transfer by their counterpart technique, while the conventional IVF group selected blastocysts based on morphological criteria. Clinicians select different controlled ovarian hyperstimulation protocols and endometrial preparation protocols based on the patient’s individual circumstances. The primary outcome was to observe the live birth rate of first frozen single-embryo transfer in each group.

Results

A total of 409 couples were enrolled in the study, of which 219 were in the PGT group, 87 were PGT-A, 22 were PGT-M, 110 were PGT-SR, and 190 were in the IVF group. The average age of patients in the PGT group was 32.90 years, while 31.53 years in the IVF group. The live birth rate was higher in the PGT group (46.12%) compared to that of the conventional IVF group (34.74%) (p = 0.0195, OR 0.6218, 95% CI 0.4161–0.9189). The live birth rate in the PGT-A subgroup (48.28%) was also higher than that in the IVF group (p = 0.032, OR 0.5703, 95% CI 0.3380–0.9610). Different controlled ovarian hyperstimulation protocols and endometrial preparation protocols had no effect on the live birth rate of PGT.

Conclusion

For first frozen single-embryo transfer, PGT, particularly PGT-A, can improve live birth rates compared to conventional IVF. Different controlled ovarian hyperstimulation protocols and endometrial preparation protocols had no effect on the live birth rate of PGT.

背景:胚胎选择和胚胎植入前基因检测(PGT)用于临床实践,目的是改善患者的妊娠结局。然而,与传统的体外受精(IVF)相比,不同的PGT技术是否能提高患者的活产率仍不确定。方法:在这项单中心回顾性队列研究中,我们纳入了经历第一个ivf辅助受孕周期且仅进行第一个冷冻胚胎移植的夫妇。所有夫妇均通过胞浆内单精子注射(ICSI)受精,并在胚胎培养第5天产生3个或更多高质量的囊胚。PGT组通过相应的技术筛选最佳囊胚进行移植,而常规IVF组根据形态学标准选择囊胚。临床医生根据患者的个体情况选择不同的控制卵巢过度刺激方案和子宫内膜准备方案。主要观察各组首次冷冻单胚胎移植的活产率。结果:共纳入409对夫妇,其中PGT组219对,PGT-A组87对,PGT- m组22对,PGT- sr组110对,IVF组190对。PGT组患者平均年龄32.90岁,IVF组患者平均年龄31.53岁。PGT组活产率(46.12%)高于常规IVF组(34.74%)(p = 0.0195, OR 0.6218, 95% CI 0.4161 ~ 0.9189)。PGT-A组的活产率(48.28%)也高于IVF组(p = 0.032, OR 0.5703, 95% CI 0.3380-0.9610)。不同的控制卵巢过度刺激方案和子宫内膜准备方案对PGT的活产率没有影响。结论:对于首次冷冻单胚胎移植,PGT,特别是PGT- a,与常规IVF相比,可以提高活产率。不同的控制卵巢过度刺激方案和子宫内膜准备方案对PGT的活产率没有影响。
{"title":"Live birth rates with and without preimplantation genetic testing: a single-center retrospective study","authors":"Yicheng Wang,&nbsp;Xinting Yu,&nbsp;Yacong Wang,&nbsp;Wending Teng,&nbsp;Hong Xian,&nbsp;Fang Wang","doi":"10.1007/s00404-025-08225-x","DOIUrl":"10.1007/s00404-025-08225-x","url":null,"abstract":"<div><h3>Background</h3><p>Embryo selection and preimplantation genetic testing (PGT) are used in clinical practice with the aim of improving pregnancy outcomes in patients. However, it remains uncertain whether different PGT techniques improve the live birth rate in patients compared to conventional in vitro fertilization (IVF).</p><h3>Methods</h3><p>In this single-center retrospective cohort study, we included couples undergoing their first IVF-assisted conception cycle with only their first single frozen embryo transfer. All couples were fertilized by intracytoplasmic sperm injection (ICSI) and had three or more high-quality blastocysts on the fifth day of embryo culture. The PGT group screened the optimal blastocysts for transfer by their counterpart technique, while the conventional IVF group selected blastocysts based on morphological criteria. Clinicians select different controlled ovarian hyperstimulation protocols and endometrial preparation protocols based on the patient’s individual circumstances. The primary outcome was to observe the live birth rate of first frozen single-embryo transfer in each group.</p><h3>Results</h3><p>A total of 409 couples were enrolled in the study, of which 219 were in the PGT group, 87 were PGT-A, 22 were PGT-M, 110 were PGT-SR, and 190 were in the IVF group. The average age of patients in the PGT group was 32.90 years, while 31.53 years in the IVF group. The live birth rate was higher in the PGT group (46.12%) compared to that of the conventional IVF group (34.74%) (<i>p</i> = 0.0195, OR 0.6218, 95% CI 0.4161–0.9189). The live birth rate in the PGT-A subgroup (48.28%) was also higher than that in the IVF group (<i>p</i> = 0.032, OR 0.5703, 95% CI 0.3380–0.9610). Different controlled ovarian hyperstimulation protocols and endometrial preparation protocols had no effect on the live birth rate of PGT.</p><h3>Conclusion</h3><p>For first frozen single-embryo transfer, PGT, particularly PGT-A, can improve live birth rates compared to conventional IVF. Different controlled ovarian hyperstimulation protocols and endometrial preparation protocols had no effect on the live birth rate of PGT.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"2269 - 2278"},"PeriodicalIF":2.5,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08225-x.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145343041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mini-laparotomic-assisted laparoscopic radical hysterectomy: an innovative technique for cervical cancer surgery—a case series 微型剖腹辅助腹腔镜根治性子宫切除术:宫颈癌手术的创新技术-病例系列。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-22 DOI: 10.1007/s00404-025-08224-y
Ala Aiob, Dina Gumin, Avishalom Sharon, Lior Lowenstein

Purpose

To assess the feasibility, safety, and short-term surgical outcomes of mini-laparotomic-assisted laparoscopic radical hysterectomy in the treatment of early-stage cervical cancer. This pilot feasibility case series is the first to provide a detailed description of the technique and its initial clinical results.

Methods

A retrospective case series of seven women with early-stage cervical cancer underwent mini-laparotomic-assisted laparoscopic radical hysterectomy at a single tertiary care center between November 2023 and October 2024. The surgical procedure included laparoscopic pelvic lymphadenectomy, radical hysterectomy, and salpingectomy, followed by colpotomy and uterine extraction through a mini-laparotomy (4–8 cm). Data on baseline characteristics, intraoperative parameters, and postoperative outcomes were collected and analyzed retrospectively.

Results

The median age was 50 years (range 42–76), and the median BMI was 27.9 kg/m2 (range 20–43). Histological subtypes included five cases of squamous cell carcinoma, one case of adenocarcinoma, and one case of adenosquamous carcinoma. Pathological staging revealed IB2 in three patients, IA1 in two, and one each for IB1 and IA2. The median operative time was 345 min (range 295–395), and the median estimated blood loss was 500 mL (range 200–700). No intraoperative or postoperative complications were reported.

Conclusion

Mini-laparotomic-assisted laparoscopic radical hysterectomy appears to be a feasible and safe surgical option for early-stage cervical cancer. This technique combines the oncologic rigor of open surgery with the advantages of minimally invasive methods, addressing significant limitations of conventional laparoscopy, including tumor manipulation and intracorporeal colpotomy performed under CO₂ pneumoperitoneum. As the initial report describing this approach, the findings support its potential as an effective alternative to the traditional open radical hysterectomy. Further studies involving larger cohorts and long-term follow-up are needed to validate its oncologic and perioperative benefits.

目的:探讨微创辅助腹腔镜根治性子宫切除术治疗早期宫颈癌的可行性、安全性及近期手术效果。这个试点可行性案例系列是第一个提供该技术及其初步临床结果的详细描述。方法:回顾性分析7例早期宫颈癌患者于2023年11月至2024年10月在同一三级医疗中心行微创辅助腹腔镜根治性子宫切除术。手术包括腹腔镜盆腔淋巴结切除术、根治性子宫切除术和输卵管切除术,随后进行阴道切开术和小剖腹(4-8厘米)子宫取出术。收集基线特征、术中参数和术后结果的数据并进行回顾性分析。结果:中位年龄为50岁(范围42-76),中位BMI为27.9 kg/m2(范围20-43)。组织学亚型包括5例鳞状细胞癌,1例腺癌,1例腺鳞癌。病理分期显示IB2 3例,IA1 2例,IB1和IA2各1例。中位手术时间345分钟(范围295-395),中位估计失血量500 mL(范围200-700)。术中及术后无并发症。结论:小腹腔镜辅助腹腔镜根治性子宫切除术是治疗早期宫颈癌的一种可行且安全的手术选择。该技术结合了开放手术的肿瘤学严谨性和微创方法的优点,解决了传统腹腔镜手术的重大局限性,包括在CO₂气腹下进行肿瘤操作和体内阴道切开术。作为描述该方法的初步报告,研究结果支持其作为传统开放式根治性子宫切除术的有效替代方案的潜力。需要进一步的研究,包括更大的队列和长期随访,以验证其肿瘤和围手术期的益处。
{"title":"Mini-laparotomic-assisted laparoscopic radical hysterectomy: an innovative technique for cervical cancer surgery—a case series","authors":"Ala Aiob,&nbsp;Dina Gumin,&nbsp;Avishalom Sharon,&nbsp;Lior Lowenstein","doi":"10.1007/s00404-025-08224-y","DOIUrl":"10.1007/s00404-025-08224-y","url":null,"abstract":"<div><h3>Purpose</h3><p>To assess the feasibility, safety, and short-term surgical outcomes of mini-laparotomic-assisted laparoscopic radical hysterectomy in the treatment of early-stage cervical cancer. This pilot feasibility case series is the first to provide a detailed description of the technique and its initial clinical results.</p><h3>Methods</h3><p>A retrospective case series of seven women with early-stage cervical cancer underwent mini-laparotomic-assisted laparoscopic radical hysterectomy at a single tertiary care center between November 2023 and October 2024. The surgical procedure included laparoscopic pelvic lymphadenectomy, radical hysterectomy, and salpingectomy, followed by colpotomy and uterine extraction through a mini-laparotomy (4–8 cm). Data on baseline characteristics, intraoperative parameters, and postoperative outcomes were collected and analyzed retrospectively.</p><h3>Results</h3><p>The median age was 50 years (range 42–76), and the median BMI was 27.9 kg/m<sup>2</sup> (range 20–43). Histological subtypes included five cases of squamous cell carcinoma, one case of adenocarcinoma, and one case of adenosquamous carcinoma. Pathological staging revealed IB2 in three patients, IA1 in two, and one each for IB1 and IA2. The median operative time was 345 min (range 295–395), and the median estimated blood loss was 500 mL (range 200–700). No intraoperative or postoperative complications were reported.</p><h3>Conclusion</h3><p>Mini-laparotomic-assisted laparoscopic radical hysterectomy appears to be a feasible and safe surgical option for early-stage cervical cancer. This technique combines the oncologic rigor of open surgery with the advantages of minimally invasive methods, addressing significant limitations of conventional laparoscopy, including tumor manipulation and intracorporeal colpotomy performed under CO₂ pneumoperitoneum. As the initial report describing this approach, the findings support its potential as an effective alternative to the traditional open radical hysterectomy. Further studies involving larger cohorts and long-term follow-up are needed to validate its oncologic and perioperative benefits.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"2289 - 2294"},"PeriodicalIF":2.5,"publicationDate":"2025-10-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08224-y.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145342946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Inflammation-driven pathogenesis of hyperemesis gravidarum: assessing the role of pan-immune-inflammation value and hematologic parameters 妊娠剧吐的炎症驱动发病机制:评估泛免疫炎症值和血液学参数的作用。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-18 DOI: 10.1007/s00404-025-08163-8
Sevil Cicek, Ebru Inci Coskun, Nuray Abdurahmanova, Ercan Yilmaz

Objective

Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting during pregnancy that frequently leads to hospitalization and significant maternal morbidity. Despite its clinical significance, the pathogenesis of HG remains poorly understood, with systemic inflammation emerging as a possible contributing factor. The aim of this study was to investigate the role of novel inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and pan-immune-inflammation value (PIV), in the pathophysiology of HG and their association with disease severity.

Materials and methods

This retrospective case–control study included 259 pregnant women (159 with HG and 100 healthy controls) enrolled in Inonu University School of Medicine between January 2020 and August 2023. Hematologic parameters, including leukocyte, neutrophil, lymphocyte, and platelet counts and ketonuria levels, were collected from electronic medical records. Inflammatory indices (NLR, PLR, SII, and PIV) were calculated and their diagnostic performance was evaluated using receiver-operating characteristic (ROC) curve analysis. Logistic regression was used to assess the risk factors for HG. Statistical analyses were performed using SPSS version 22, with p < 0.05 considered significant.

Results

The HG group had significantly higher NLR (p = 0.004), PLR (p = 0.003), SII (p < 0.001), and PIV (p < 0.001) compared to controls. ROC analysis revealed that NLR [cut-off: 5.67, area under the curve (AUC) 0.608, 95% confidence interval (CI) 0.545–0.668, p = 0.002], PLR (cut-off: 154.5, AUC 0.610, 95% CI 0.547–0.669, p = 0.002), SII (cut-off: 948.4, AUC: 0.636, 95% CI 0.575–0.695, p < 0.001), and PIV (cut-off: 866.51, AUC 0.637, 95% CI 0.575–0.696, p < 0.001) showed moderate diagnostic performance with high specificity (70–94%) but variable sensitivity (25.8–55.3%). Logistic regression identified low gestational age and increased platelet distribution width (PDW) as significant risk factors for HG (p < 0.05), while PIV and other inflammatory markers did not emerge as independent predictors.

Conclusion

This study emphasizes the role of systemic inflammation in HG as evidenced by increased inflammatory indices in HG patients. NLR, PLR, SII, and PIV prove to be promising diagnostic markers for HG and offer high specificity and sensitivity. However, their lack of correlation with ketonuria suggests that inflammation alone cannot fully explain the severity of the disease. These findings highlight the need for further research to validate these markers and explore their potential for the development of personalized treatment strategies for HG.

目的:妊娠剧吐(Hyperemesis gravidarum, HG)是妊娠期恶心和呕吐的一种严重形式,经常导致住院治疗和显著的孕产妇发病率。尽管具有临床意义,但HG的发病机制尚不清楚,全身性炎症可能是一个促成因素。本研究的目的是探讨新的炎症标志物,包括中性粒细胞与淋巴细胞比值(NLR)、血小板与淋巴细胞比值(PLR)、全身免疫炎症指数(SII)和泛免疫炎症值(PIV)在HG病理生理中的作用及其与疾病严重程度的关系。材料和方法:本回顾性病例对照研究纳入了2020年1月至2023年8月在猪女大学医学院注册的259名孕妇(159名HG患者和100名健康对照)。从电子病历中收集血液学参数,包括白细胞、中性粒细胞、淋巴细胞、血小板计数和酮尿水平。计算炎症指数(NLR、PLR、SII和PIV),并采用受试者工作特征(ROC)曲线分析评估其诊断效能。采用Logistic回归评估HG的危险因素。采用SPSS 22版进行统计分析,结果:HG组NLR (p = 0.004)、PLR (p = 0.003)、SII (p)显著高于HG组。结论:HG患者炎症指数升高,表明该研究强调了全身性炎症在HG中的作用。NLR、PLR、SII和PIV被证明是有希望的HG诊断标志物,具有高特异性和敏感性。然而,它们与酮症尿缺乏相关性表明,炎症本身并不能完全解释疾病的严重性。这些发现强调需要进一步研究来验证这些标记物,并探索它们在HG个性化治疗策略开发方面的潜力。
{"title":"Inflammation-driven pathogenesis of hyperemesis gravidarum: assessing the role of pan-immune-inflammation value and hematologic parameters","authors":"Sevil Cicek,&nbsp;Ebru Inci Coskun,&nbsp;Nuray Abdurahmanova,&nbsp;Ercan Yilmaz","doi":"10.1007/s00404-025-08163-8","DOIUrl":"10.1007/s00404-025-08163-8","url":null,"abstract":"<div><h3>Objective</h3><p>Hyperemesis gravidarum (HG) is a severe form of nausea and vomiting during pregnancy that frequently leads to hospitalization and significant maternal morbidity. Despite its clinical significance, the pathogenesis of HG remains poorly understood, with systemic inflammation emerging as a possible contributing factor. The aim of this study was to investigate the role of novel inflammatory markers, including neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), systemic immune-inflammation index (SII), and pan-immune-inflammation value (PIV), in the pathophysiology of HG and their association with disease severity.</p><h3>Materials and methods</h3><p>This retrospective case–control study included 259 pregnant women (159 with HG and 100 healthy controls) enrolled in Inonu University School of Medicine between January 2020 and August 2023. Hematologic parameters, including leukocyte, neutrophil, lymphocyte, and platelet counts and ketonuria levels, were collected from electronic medical records. Inflammatory indices (NLR, PLR, SII, and PIV) were calculated and their diagnostic performance was evaluated using receiver-operating characteristic (ROC) curve analysis. Logistic regression was used to assess the risk factors for HG. Statistical analyses were performed using SPSS version 22, with <i>p</i> &lt; 0.05 considered significant.</p><h3>Results</h3><p>The HG group had significantly higher NLR (<i>p</i> = 0.004), PLR (<i>p</i> = 0.003), SII (<i>p</i> &lt; 0.001), and PIV (<i>p</i> &lt; 0.001) compared to controls. ROC analysis revealed that NLR [cut-off: 5.67, area under the curve (AUC) 0.608, 95% confidence interval (CI) 0.545–0.668, <i>p</i> = 0.002], PLR (cut-off: 154.5, AUC 0.610, 95% CI 0.547–0.669, <i>p</i> = 0.002), SII (cut-off: 948.4, AUC: 0.636, 95% CI 0.575–0.695, <i>p</i> &lt; 0.001), and PIV (cut-off: 866.51, AUC 0.637, 95% CI 0.575–0.696, <i>p</i> &lt; 0.001) showed moderate diagnostic performance with high specificity (70–94%) but variable sensitivity (25.8–55.3%). Logistic regression identified low gestational age and increased platelet distribution width (PDW) as significant risk factors for HG (<i>p</i> &lt; 0.05), while PIV and other inflammatory markers did not emerge as independent predictors.</p><h3>Conclusion</h3><p>This study emphasizes the role of systemic inflammation in HG as evidenced by increased inflammatory indices in HG patients. NLR, PLR, SII, and PIV prove to be promising diagnostic markers for HG and offer high specificity and sensitivity. However, their lack of correlation with ketonuria suggests that inflammation alone cannot fully explain the severity of the disease. These findings highlight the need for further research to validate these markers and explore their potential for the development of personalized treatment strategies for HG.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"2001 - 2010"},"PeriodicalIF":2.5,"publicationDate":"2025-10-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08163-8.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multicystic dysplastic kidneys (MCDK) during prenatal life and postnatal outcome 多囊性发育不良肾脏(MCDK)在产前生活和产后结局。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-17 DOI: 10.1007/s00404-025-08197-y
Charlotte Johanna Marie Reinhardt, Wolfgang Henrich, Stefan Verlohren, Julia Thumfart, Josefine Theresia Koenigbauer

Purpose

Multicystic dysplastic kidneys (MCDK) are commonly detected on prenatal ultrasound examinations, occurring in 1 in 1,000 to 4,300 live births. This study focuses on neonatal outcomes in fetuses with MCDK, with particular attention to the presence of additional anomalies.

Methods

Retrospective data of fetuses diagnosed with MCDK at Charité University Hospital between 2005 and 2022 were collected and analyzed. Rates of termination of pregnancy (TOP), intrauterine fetal demise (IUFD) and live birth were evaluated. Outcome parameters, including APGAR score, survival, neonatal ventilation therapy or respiratory adjustment disorder, were examined.

Results

A total of 103 fetuses with MCDK were identified. Eight exhibited bilateral MCDK (7.8%). 92.2% showed unilateral MCDK (n = 95), of which 43 revealed additional anomalies (45.3%). Fetuses with additional anomalies displayed significantly fewer live births, more prematurity, lower APGAR scores and lower gestational ages at birth. The expected outcome of fetuses with MCDK is contingent upon the presence of additional anomalies. Bilateral MCDK, as well as unilateral MCDK with additional anomalies, are associated with an unfavorable postnatal outcome.

Conclusion

To consult parents on the potential postnatal well-being of their offspring with MCDK, it is crucial to search for additional anomalies. Genetic counseling and invasive genetic testing should be offered.

目的:多囊性发育不良肾脏(MCDK)通常在产前超声检查中发现,发生在1,000至4,300名活产婴儿中。本研究主要关注MCDK胎儿的新生儿结局,特别关注其他异常的存在。方法:回顾性收集2005年至2022年在慈善大学医院诊断为MCDK的胎儿资料并进行分析。评估终止妊娠率(TOP)、宫内死胎率(IUFD)和活产率。结果参数包括APGAR评分、生存率、新生儿通气治疗或呼吸调节障碍。结果:共鉴定出103例MCDK胎儿。8例出现双侧MCDK(7.8%)。92.2%为单侧MCDK (n = 95),其中43例有附加异常(45.3%)。有额外异常的胎儿表现出明显更少的活产,更多的早产,更低的APGAR评分和更低的出生胎龄。MCDK胎儿的预期结果取决于其他异常的存在。双侧MCDK,以及伴有额外异常的单侧MCDK,与不利的产后结局相关。结论:为了向父母咨询MCDK后代的潜在产后健康状况,寻找其他异常是至关重要的。应提供遗传咨询和侵入性基因检测。
{"title":"Multicystic dysplastic kidneys (MCDK) during prenatal life and postnatal outcome","authors":"Charlotte Johanna Marie Reinhardt,&nbsp;Wolfgang Henrich,&nbsp;Stefan Verlohren,&nbsp;Julia Thumfart,&nbsp;Josefine Theresia Koenigbauer","doi":"10.1007/s00404-025-08197-y","DOIUrl":"10.1007/s00404-025-08197-y","url":null,"abstract":"<div><h3>Purpose</h3><p>Multicystic dysplastic kidneys (MCDK) are commonly detected on prenatal ultrasound examinations, occurring in 1 in 1,000 to 4,300 live births. This study focuses on neonatal outcomes in fetuses with MCDK, with particular attention to the presence of additional anomalies.</p><h3>Methods</h3><p>Retrospective data of fetuses diagnosed with MCDK at Charité University Hospital between 2005 and 2022 were collected and analyzed. Rates of termination of pregnancy (TOP), intrauterine fetal demise (IUFD) and live birth were evaluated. Outcome parameters, including APGAR score, survival, neonatal ventilation therapy or respiratory adjustment disorder, were examined.</p><h3>Results</h3><p>A total of 103 fetuses with MCDK were identified. Eight exhibited bilateral MCDK (7.8%). 92.2% showed unilateral MCDK (n = 95), of which 43 revealed additional anomalies (45.3%). Fetuses with additional anomalies displayed significantly fewer live births, more prematurity, lower APGAR scores and lower gestational ages at birth. The expected outcome of fetuses with MCDK is contingent upon the presence of additional anomalies. Bilateral MCDK, as well as unilateral MCDK with additional anomalies, are associated with an unfavorable postnatal outcome.</p><h3>Conclusion</h3><p>To consult parents on the potential postnatal well-being of their offspring with MCDK, it is crucial to search for additional anomalies. Genetic counseling and invasive genetic testing should be offered.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"2131 - 2146"},"PeriodicalIF":2.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08197-y.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity and dysglycemia independently predict symptom burden but not satisfaction with care in polycystic ovary syndrome: a cross-sectional study 肥胖和血糖异常独立预测多囊卵巢综合征的症状负担,但不能预测护理满意度:一项横断面研究。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-17 DOI: 10.1007/s00404-025-08219-9
Annette Bachmann, Julia Estermann, Marina Sourouni, Thomas Karn, Norman Bitterlich, Susanna Weidlinger, Petra Stute

Purpose

Polycystic ovary syndrome (PCOS) is associated with a broad range of reproductive, metabolic, and psychosocial symptoms. This study aimed to evaluate whether body mass index (BMI) and dysglycemia independently predict symptom burden and to explore how these factors relate to patient-perceived care gaps, as reflected by satisfaction with counselling.

Methods

We conducted a cross-sectional analysis of 1,926 self-identified women with PCOS. Participants reported symptom prevalence and rated satisfaction with counselling across six clinical domains using a 0–100 scale. Logistic regression models assessed associations between BMI, dysglycemia (prediabetes, gestational diabetes, type 2 diabetes), and PCOS symptoms. Multivariate linear regression was used to identify predictors of satisfaction with counselling.

Results

The most frequently reported symptoms were body image dissatisfaction (78.2%), hirsutism (75.0%), and menstrual irregularity (65.0%). Both higher BMI and dysglycemia were independently associated with increased odds of infertility (BMI: OR 1.48, 95% CI 1.38–1.58, p < 0.001; dysglycemia: OR 1.85, 95% CI 1.50–2.28, p < 0.001), as well as with depression, anxiety, alopecia, and hirsutism (all p < 0.001)Dysglycemia was not significantly associated with acne or menstrual irregularity. Mean satisfaction with PCOS counselling was low (35.1 ± 26.9), with the lowest scores reported for aesthetic concerns (31.4 ± 27.8). In adjusted models, depression, alopecia, body image dissatisfaction, and hirsutism were independently associated with lower satisfaction. BMI and dysglycemia were not independently associated with satisfaction after accounting for symptoms.

Conclusion

While obesity and dysglycemia contribute to increased PCOS symptom burden, they do not explain low satisfaction with care. Perceived care gaps are most pronounced in emotional and aesthetic domains, indicating the need for more holistic, patient-centered PCOS care models.

目的:多囊卵巢综合征(PCOS)与广泛的生殖、代谢和社会心理症状相关。本研究旨在评估体重指数(BMI)和血糖异常是否能独立预测症状负担,并探讨这些因素与患者感知的护理差距(通过咨询满意度反映)之间的关系。方法:我们对1926名自认为患有多囊卵巢综合征的女性进行了横断面分析。参与者报告了症状的流行程度,并使用0-100的量表对六个临床领域的咨询满意度进行了评分。Logistic回归模型评估BMI、血糖异常(前驱糖尿病、妊娠糖尿病、2型糖尿病)和多囊卵巢综合征症状之间的关联。使用多元线性回归来确定咨询满意度的预测因子。结果:最常见的症状是身体形象不满意(78.2%)、多毛(75.0%)和月经不规律(65.0%)。较高的BMI和血糖异常均与不孕几率增加独立相关(BMI: OR 1.48, 95% CI 1.38-1.58, p)。结论:虽然肥胖和血糖异常导致多囊卵巢综合征症状负担增加,但它们不能解释低护理满意度。感知到的护理差距在情感和审美领域最为明显,这表明需要更全面、以患者为中心的多囊卵巢综合征护理模式。
{"title":"Obesity and dysglycemia independently predict symptom burden but not satisfaction with care in polycystic ovary syndrome: a cross-sectional study","authors":"Annette Bachmann,&nbsp;Julia Estermann,&nbsp;Marina Sourouni,&nbsp;Thomas Karn,&nbsp;Norman Bitterlich,&nbsp;Susanna Weidlinger,&nbsp;Petra Stute","doi":"10.1007/s00404-025-08219-9","DOIUrl":"10.1007/s00404-025-08219-9","url":null,"abstract":"<div><h3>Purpose</h3><p>Polycystic ovary syndrome (PCOS) is associated with a broad range of reproductive, metabolic, and psychosocial symptoms. This study aimed to evaluate whether body mass index (BMI) and dysglycemia independently predict symptom burden and to explore how these factors relate to patient-perceived care gaps, as reflected by satisfaction with counselling.</p><h3>Methods</h3><p>We conducted a cross-sectional analysis of 1,926 self-identified women with PCOS. Participants reported symptom prevalence and rated satisfaction with counselling across six clinical domains using a 0–100 scale. Logistic regression models assessed associations between BMI, dysglycemia (prediabetes, gestational diabetes, type 2 diabetes), and PCOS symptoms. Multivariate linear regression was used to identify predictors of satisfaction with counselling.</p><h3>Results</h3><p>The most frequently reported symptoms were body image dissatisfaction (78.2%), hirsutism (75.0%), and menstrual irregularity (65.0%). Both higher BMI and dysglycemia were independently associated with increased odds of infertility (BMI: OR 1.48, 95% CI 1.38–1.58, <i>p</i> &lt; 0.001; dysglycemia: OR 1.85, 95% CI 1.50–2.28, <i>p</i> &lt; 0.001), as well as with depression, anxiety, alopecia, and hirsutism (all <i>p</i> &lt; 0.001)Dysglycemia was not significantly associated with acne or menstrual irregularity. Mean satisfaction with PCOS counselling was low (35.1 ± 26.9), with the lowest scores reported for aesthetic concerns (31.4 ± 27.8). In adjusted models, depression, alopecia, body image dissatisfaction, and hirsutism were independently associated with lower satisfaction. BMI and dysglycemia were not independently associated with satisfaction after accounting for symptoms.</p><h3>Conclusion</h3><p>While obesity and dysglycemia contribute to increased PCOS symptom burden, they do not explain low satisfaction with care. Perceived care gaps are most pronounced in emotional and aesthetic domains, indicating the need for more holistic, patient-centered PCOS care models.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"2241 - 2250"},"PeriodicalIF":2.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08219-9.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Timing and survival benefits of cytoreduction in patients with recurrent leiomyosarcoma 复发性平滑肌肉瘤患者细胞减少的时间和生存益处。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-17 DOI: 10.1007/s00404-025-08140-1
Mehmet Tunç, Hüseyin Akıllı, Esra Kuşçu, Ali Ayhan

Purpose

Leiomyosarcoma is characterized by its aggressive behavior, poor prognosis, resistance to chemotherapeutic drugs, and high recurrence rate. This study aimed to identify prognostic factors affecting the effectiveness of cytoreductive surgery (CRS) on overall survival (OS) in patients with recurrent leiomyosarcoma (LMS).

Methods

A retrospective analysis was conducted at Başkent University Ankara Hospital from 2007 to 2016, involving 59 patients with uterine LMS who underwent surgery. We assessed demographic and clinical variables, disease recurrence intervals, and treatment outcomes.

Results

The median age of the patients was 50.0 (23–78) years, and the median follow-up time was 25.0 (2–87) months. Median disease-free survival (DFS) and OS were 15.0 and 37.0 months, respectively. Disease recurrence occurred in 44 patients (74.6%). After recurrence, 34 (77.3%) patients underwent CRS and chemotherapy (CT), while 10 (22.7%) patients received only CT. The median OS was 19.0 months for patients who underwent CRS and received CT and 15.0 months for those who received only CT (p = 0.132). Notably, OS was significantly longer for patients whose recurrence occurred after 6 months compared to those with early recurrence (19 versus 8 months, p = 0.049).

Conclusion

CRS provided a modest survival benefit for patients with recurrent LMS, although statistical significance was not achieved. The results of this study indicate that the timing of recurrence plays a crucial role in survival.

目的:平滑肌肉瘤具有侵袭性强、预后差、对化疗药物耐药、复发率高等特点。本研究旨在确定影响细胞减少手术(CRS)对复发性平滑肌肉瘤(LMS)患者总生存(OS)有效性的预后因素。方法:回顾性分析2007 - 2016年在安卡拉大学附属医院接受手术治疗的59例子宫LMS患者的资料。我们评估了人口统计学和临床变量、疾病复发间隔和治疗结果。结果:患者中位年龄50.0(23-78)岁,中位随访时间25.0(2-87)个月。中位无病生存期(DFS)和OS分别为15.0和37.0个月。44例(74.6%)出现疾病复发。复发后,34例(77.3%)患者行CRS +化疗(CT), 10例(22.7%)患者仅行CT。接受CRS并接受CT的患者中位OS为19.0个月,仅接受CT的患者中位OS为15.0个月(p = 0.132)。值得注意的是,6个月后复发的患者的OS明显长于早期复发的患者(19个月vs 8个月,p = 0.049)。结论:CRS为复发性LMS患者提供了适度的生存获益,尽管没有达到统计学意义。本研究结果表明,复发的时机在生存中起着至关重要的作用。
{"title":"Timing and survival benefits of cytoreduction in patients with recurrent leiomyosarcoma","authors":"Mehmet Tunç,&nbsp;Hüseyin Akıllı,&nbsp;Esra Kuşçu,&nbsp;Ali Ayhan","doi":"10.1007/s00404-025-08140-1","DOIUrl":"10.1007/s00404-025-08140-1","url":null,"abstract":"<div><h3>Purpose</h3><p>Leiomyosarcoma is characterized by its aggressive behavior, poor prognosis, resistance to chemotherapeutic drugs, and high recurrence rate. This study aimed to identify prognostic factors affecting the effectiveness of cytoreductive surgery (CRS) on overall survival (OS) in patients with recurrent leiomyosarcoma (LMS).</p><h3>Methods</h3><p>A retrospective analysis was conducted at Başkent University Ankara Hospital from 2007 to 2016, involving 59 patients with uterine LMS who underwent surgery. We assessed demographic and clinical variables, disease recurrence intervals, and treatment outcomes.</p><h3>Results</h3><p>The median age of the patients was 50.0 (23–78) years, and the median follow-up time was 25.0 (2–87) months. Median disease-free survival (DFS) and OS were 15.0 and 37.0 months, respectively. Disease recurrence occurred in 44 patients (74.6%). After recurrence, 34 (77.3%) patients underwent CRS and chemotherapy (CT), while 10 (22.7%) patients received only CT. The median OS was 19.0 months for patients who underwent CRS and received CT and 15.0 months for those who received only CT (<i>p</i> = 0.132). Notably, OS was significantly longer for patients whose recurrence occurred after 6 months compared to those with early recurrence (19 versus 8 months, <i>p</i> = 0.049).</p><h3>Conclusion</h3><p>CRS provided a modest survival benefit for patients with recurrent LMS, although statistical significance was not achieved. The results of this study indicate that the timing of recurrence plays a crucial role in survival.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"1985 - 1990"},"PeriodicalIF":2.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08140-1.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Matters arising: single-versus double-layer uterine closure at the time of cesarean delivery and risk of uterine scar niche 发生事项:剖宫产时单层与双层子宫闭合及子宫瘢痕龛的风险。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-17 DOI: 10.1007/s00404-025-08211-3
Gabriel Moreira Lino, George Alessandro Maranhão Conrado
{"title":"Matters arising: single-versus double-layer uterine closure at the time of cesarean delivery and risk of uterine scar niche","authors":"Gabriel Moreira Lino,&nbsp;George Alessandro Maranhão Conrado","doi":"10.1007/s00404-025-08211-3","DOIUrl":"10.1007/s00404-025-08211-3","url":null,"abstract":"","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 5","pages":"1543 - 1544"},"PeriodicalIF":2.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08211-3.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive effects of laparoscopic sacrocolpopexy on anterior lateral defects and stress urinary incontinence 腹腔镜骶髋固定术治疗前外侧缺损和压力性尿失禁的积极效果。
IF 2.5 3区 医学 Q2 OBSTETRICS & GYNECOLOGY Pub Date : 2025-10-17 DOI: 10.1007/s00404-025-08214-0
Norbert Nosal, Sebastian Ludwig, Markus Huebner

Objective

Laparoscopic sacrocolpopexy (SCP) is considered the gold standard for the correction of middle compartment (apical) prolapse. The extent to which simultaneous correction of the anterior compartment is necessary remains unclear. The aim of this study was to examine the anatomical and functional outcomes of the SCP on the anterior compartment with respect to the correction of central and lateral defects as well as stress urinary incontinence (SUI).

Methods

This was a retrospective clinical follow-up with records of recurrences and complications as well as effects on SUI after laparoscopic SCP with and without simultaneous vaginal correction at Elisabeth Hospital, Essen, Germany, from 2014–2020 in 65 of 86 patients, with an average follow-up of 3.3 years.

Results

Without simultaneous vaginal correction of the anterior compartment, recurrence was more common in women with central defect POP-Q Ba > − 2.0 [4 of 8 patients without correction (50% recurrence) vs. 1 of 23 patients with correction (4% recurrence)]. The OR for recurrence with surgery was 0.05 (95% CI 0.01; 0.52, p < 0,001). In women with lateral defects of the anterior compartment with a POP-Q Ba > − 2.0, simultaneous vaginal correction was not necessary, with a low recurrence rate (1 of 18 recurrences, 6%). Preexisting SUI grade ≥ 1 could be corrected in 27 of 36 patients. (75%, p < 0,001) according to the SCP.

Mesh erosion with reoperation (Clavien–Dindo IIIb) occurred in three patients (4.6%).

Conclusion

Overall, this study suggests that patients with a central defect of the anterior vaginal wall can benefit from additional vaginal correction as part of the SCP. Furthermore, existing incontinence improves with the correction of prolapse.

目的:腹腔镜骶colpop固定术(SCP)被认为是矫正中腔室(根尖)脱垂的金标准。在多大程度上同时矫正前房室是必要的仍不清楚。本研究的目的是检查SCP在前腔室的解剖和功能结果,以纠正中央和外侧缺陷以及压力性尿失禁(SUI)。方法:回顾性临床随访,记录2014-2020年德国埃森Elisabeth医院86例患者中65例(平均随访3.3年)伴或不伴阴道矫正的腹腔镜SCP术后复发、并发症及对SUI的影响。结果:未同时阴道前房室矫正,中枢性缺损患者(POP-Q Ba > - 2.0)的复发更为常见[8例未矫正患者中有4例(50%复发)vs. 23例矫正患者中有1例(4%复发)]。手术后复发的OR为0.05 (95% CI 0.01; 0.52, p - 2.0),无需同时阴道矫正,复发率低(1 / 18复发,6%)。36例患者中有27例可纠正先前存在的SUI等级≥1。结论:总的来说,本研究表明阴道前壁中心缺损的患者可以从作为SCP的一部分的额外阴道矫正中获益。此外,现有的尿失禁随着脱垂的矫正而改善。
{"title":"Positive effects of laparoscopic sacrocolpopexy on anterior lateral defects and stress urinary incontinence","authors":"Norbert Nosal,&nbsp;Sebastian Ludwig,&nbsp;Markus Huebner","doi":"10.1007/s00404-025-08214-0","DOIUrl":"10.1007/s00404-025-08214-0","url":null,"abstract":"<div><h3>Objective</h3><p>Laparoscopic sacrocolpopexy (SCP) is considered the gold standard for the correction of middle compartment (apical) prolapse. The extent to which simultaneous correction of the anterior compartment is necessary remains unclear. The aim of this study was to examine the anatomical and functional outcomes of the SCP on the anterior compartment with respect to the correction of central and lateral defects as well as stress urinary incontinence (SUI).</p><h3>Methods</h3><p>This was a retrospective clinical follow-up with records of recurrences and complications as well as effects on SUI after laparoscopic SCP with and without simultaneous vaginal correction at Elisabeth Hospital, Essen, Germany, from 2014–2020 in 65 of 86 patients, with an average follow-up of 3.3 years.</p><h3>Results</h3><p>Without simultaneous vaginal correction of the anterior compartment, recurrence was more common in women with central defect POP-Q Ba &gt; − 2.0 [4 of 8 patients without correction (50% recurrence) vs. 1 of 23 patients with correction (4% recurrence)]. The OR for recurrence with surgery was 0.05 (95% CI 0.01; 0.52, <i>p</i> &lt; 0,001). In women with lateral defects of the anterior compartment with a POP-Q Ba &gt; − 2.0, simultaneous vaginal correction was not necessary, with a low recurrence rate (1 of 18 recurrences, 6%). Preexisting SUI grade ≥ 1 could be corrected in 27 of 36 patients. (75%, <i>p</i> &lt; 0,001) according to the SCP.</p><p>Mesh erosion with reoperation (Clavien–Dindo IIIb) occurred in three patients (4.6%).</p><h3>Conclusion</h3><p>Overall, this study suggests that patients with a central defect of the anterior vaginal wall can benefit from additional vaginal correction as part of the SCP. Furthermore, existing incontinence improves with the correction of prolapse.</p></div>","PeriodicalId":8330,"journal":{"name":"Archives of Gynecology and Obstetrics","volume":"312 6","pages":"2233 - 2240"},"PeriodicalIF":2.5,"publicationDate":"2025-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://link.springer.com/content/pdf/10.1007/s00404-025-08214-0.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145312409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Archives of Gynecology and Obstetrics
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1